NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bright Minds Biosciences Inc (CN: DRUG)

 
DRUG Technical Analysis
5
As on 7th May 2025 DRUG STOCK Price closed @ 41.90 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.87 & Strong Buy for SHORT-TERM with Stoploss of 1.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DRUGSTOCK Price

Open 41.90 Change Price %
High 41.90 1 Day 0.90 2.20
Low 41.90 1 Week -3.15 -6.99
Close 41.90 1 Month -6.99 -14.30
Volume 100 1 Year 39.70 1804.55
52 Week High 102.72 | 52 Week Low 1.30
 
CN Canada Most Active Stocks
BIGG 0.22 15.79%
ACDC 0.06 0.00%
BOLT 0.01 0.00%
VC 0.02 100.00%
NTAR 0.02 -33.33%
FMAN 0.55 7.84%
TER 2.80 5.66%
SOL 0.10 -16.67%
GSK 0.54 20.00%
PREV 0.03 -25.00%
 
CN Canada Top Gainers Stocks
CCC 0.02 100.00%
CCC 0.02 100.00%
CCC 0.02 100.00%
CCC 0.02 100.00%
VC 0.02 100.00%
VC 0.02 100.00%
OWLI 0.02 100.00%
MICH 0.13 62.50%
SQX 0.03 50.00%
RVV 0.03 50.00%
 
CN Canada Top Losers Stocks
GTG 0.37 -97.30%
GTG 0.37 -97.30%
CODE 1.20 -65.12%
CODE 1.20 -65.12%
ISFT 0.04 -50.00%
ISFT 0.04 -50.00%
QQ 0.03 -50.00%
QQ 0.03 -50.00%
ASTI 0.01 -50.00%
ASTI 0.01 -50.00%
 
 
DRUG
Daily Charts
DRUG
Intraday Charts
Whats New @
Bazaartrend
DRUG
Free Analysis
 
DRUG Important Levels Intraday
RESISTANCE41.90
RESISTANCE41.90
RESISTANCE41.90
RESISTANCE41.90
RESISTANCE41.90
RESISTANCE41.90
RESISTANCE41.90
RESISTANCE41.90
 
DRUG Forecast May 2025
4th UP Forecast42.86
3rd UP Forecast42.55
2nd UP Forecast42.36
1st UP Forecast42.17
1st DOWN Forecast41.63
2nd DOWN Forecast41.44
3rd DOWN Forecast41.25
4th DOWN Forecast40.94
 
DRUG Weekly Forecast
4th UP Forecast42.25
3rd UP Forecast42.14
2nd UP Forecast42.07
1st UP Forecast42.00
1st DOWN Forecast41.80
2nd DOWN Forecast41.73
3rd DOWN Forecast41.66
4th DOWN Forecast41.55
 
DRUG Forecast2025
4th UP Forecast247.53
3rd UP Forecast181.58
2nd UP Forecast140.82
1st UP Forecast100.06
1st DOWN Forecast-16.26
2nd DOWN Forecast-57.02
3rd DOWN Forecast-97.78
4th DOWN Forecast-163.73
 
 
DRUG Other Details
Segment EQ
Market Capital 101184120.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
DRUG Address
DRUG
 
DRUG Latest News
 
Your Comments and Response on Bright Minds Biosciences Inc
 
DRUG Business Profile
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Address: 1500 ? 1055 West Georgia Street, Vancouver, BC, Canada, V6E 4N7
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service